Research Group
Cancer Biomarkers
Sponsor
Icahn School of Medicine at Mount Sinai
Status
Enrolling by invitation
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04539717
The purpose of this study is to compare the diagnostic value of a reconstructed abbreviated Magnetic Resonance Imaging (MRI) from a full clinical exam, compared to ultrasound (US) for screening of liver cancer. Blood markers will be evaluated to determine their correlation to imaging. This study will help to determine whether abbreviated MRI is superior to ultrasound for diagnosis of liver cancer.
Condition
Hepatocellular Carcinoma (HCC), Liver Cirrhosis
Investigators
Bachir Taouli